Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S17 pseudogene 5 (RPS17P5) is classified as a **processed pseudogene**[5][8]. It is one of multiple non-functional copies in the human genome that resemble the gene encoding ribosomal protein S17 (RPS17), but does not encode a functional protein product. Unlike protein-coding genes, pseudogenes such as RPS17P5 do not have a well-defined biological or molecular function[5][8]. It is annotated as a pseudogene in major genetic databases and is not considered a receptor, enzyme, transporter, or any conventional drug target[5]. There are no known drug interactions, disease associations, or clinical utility for RPS17P5. Its presence is purely genomic, with no established transcriptional or translational activity impacting cellular phenotypes[5][8]. If you require structured target information for canonical protein-coding ribosomal protein S17 (not the pseudogene), refer instead to "Ribosomal protein S17" (RPS17)[2][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S17 pseudogene 5 (RPS17P5).